• Journal of Hospice and Palliative Care
• /
• 제14권4호
• /
• pp.218-226
• /
• 2011

목적: 본 연구는 국가 차원의 암 생존자 관리 프로그램 개발과 관련한 일반대중들의 태도를 조사하고 분석하여, 국가 암 생존자 관리를 위한 정책과 제도 마련에 대한 필요성을 제시하고자 한다. 방법: 16개 시도시의 20세 이상 성인남녀 1,015명을 대상으로 성별, 연령별, 시도별 인구분포에 의한 할당추출 인구 구성비와 동일하게 대상자를 추출하여 조사를 실시하였다. 인구학적 특성, 암과 관련된 인식, 암 생존자 관리를 위한 국가 프로그램에 대한 태도를 포함한 구조화된 설문지를 사용하여 전화 면접조사를 실시하였다. 결과: 암 치료 후 국가차원의 지속적인 관리 필요성에 대해 응답자의 56%가 '매우 그렇다', 27%가 '그런 편이다'라고 응답하였다. 관리의 내용으로는 29.8%가 '치료 후 진료 또는 관리에 대한 보험 적용확대'로 가장 많았으며, '암 치료 후 체계적인 교육 및 재활 프로그램 제공'이 25.6%이었다. 교육 수준이 낮거나[adjusted odds ratio (aOR)=1.36; 95% confidence interval (CI)=1.04~1.77], 기혼이거나[aOR=1.79; 95% CI=1.34~2.37], 경제수준이 낮거나[aOR=1.36; 95% CI=1.04~1.77], 선진국 대비 치료수준이 높다는 견해를 가진 경우[aOR=1.56; 95% CI=1.15~2.12] 그렇지 않은 경우보다 암 치료 후 국가차원의 관리 필요성에 공감하는 것으로 나타났다. 암환자 장애인 인정 정책에 대해서는 대상자의 68%가 적극 찬성 또는 찬성한다고 응답하였으며, 교육수준이 낮을 수록[aOR=1.35; 95% CI=1.03~1.78], 기혼인 경우[aOR=1.89; 95% CI=1.41~2.53] 그렇지 않은 경우보다 더 찬성하는 것으로 나타났다. 결론: 암 생존자 관리를 위한 국가 차원의 프로그램에 대한 일반 국민들의 태도는 전반적으로 긍정적임을 확인할 수 있었다.

• 대한장애인치과학회지
• /
• 제15권1호
• /
• pp.23-28
• /
• 2019

다발성 우식이 있는 청소년 지적장애 환자들은 협조도가 불량하고 치료 부위가 광범위하며 구강 관리 유지가 어려울 수 있다. 따라서 장애와 환자의 상태에 맞게 최소 침습적 치료보다는 적극적인 크라운 수복 치료와 유지관리 및 보호자와 환자를 대상으로 식이 관리 및 칫솔질 교육을 진행하도록 해야한다. 청소년기 다발성 우식이 있는 지적장애 환자에 대해 더 적극적인 치료와 양호한 유지관리가 이루어지도록 치과의사와 보호자 모두 적극적인 노력이 이루어져야 할 것이다. 환자 맞춤의 치과 치료 방법을 선택하고 보호자 교육을 통해 이를 유지관리 및 예방에 힘쓸 수 있게 해야 하며, 보호자는 개선된 구강상태를 유지하고 예방하기 위해 가정에서의 구강위생관리를 중요하게 잘 수행해야 할 것이다.

• 대한본초학회지
• /
• 제27권2호
• /
• pp.1-16
• /
• 2012

Objective : To investigate the current status of prescription drugs in Oriental medical institutes and to draw up a future plan for the revitalization of Oriental medical health insurance, this survey has been performed. Method : The survey has been made with 321 doctors working at Oriental medical institutes in Daegu and Kyungbuk areas for a period of 3 month from June 1, 2010 until September 1, 2010. Result : 1. When it comes to the current status of the use of herbal drugs in Oriental Health insurance, most of doctors surveyed prescribe insurance drugs, and they prescribe insurance drugs to patients, who are less than 20% of total patients visiting their clinics. 2. The awareness of Herbal Health Care Drugs is investigated. When it comes to the understanding of the difference between insurance drugs(powder type drugs) and granular type drugs, doctors admit that they differ only in one aspect, whether or not their being covered by health insurance. Based on the survey results on the understanding of insurance coverage of granular type drugs, doctors, even though they long for granular type drugs to be accepted as insurance drugs, are worrying whether the number of outpatients might dwindle due to increased insurance co-payments. They also point out that the biggest obstacles in the expansion of the granular type drugs as insurance drugs are the lack of understanding of the government and the objection of the Health Insurance Review and Assesment service (HIRA) for fear of increased insurance claims. 3. Upon investigation on Oriental medicine doctors' understandings of herbal pharmaceutical industry, it is found that doctors' responses on pharmaceutical industry are not all positive ones('new product development and neglect of R&D infrastructure' and 'smallness of industry'). When it is investigated what area needs the greatest improvement in herbal pharmaceutical industry, 'securing sufficient capital, good manufacturing, and strengthening quality control', is the highest. 4. When it is asked what are the most needed in order to improve herbal health insurance medicine, responses such as 'the increase in the accessibility to and the utilization of Oriental medical clinics through the diversification of the means of prescriptions', 'the improvement of insurance benefits(cap adjustments)', 'increase the proportion of high quality medicinal plants', 'the ceiling of co-payments(deductible) at 20,000 won or more', 'expansion of the choices of formulations', 'formulational expansions of tablets and pills', and finally 'admittance and expansion of granular type drug as insurance drug' are the highest. 5. Upon investigating the general characteristics of the current status of the usage of Oriental health care herbal drugs, the followings are observed. First, the frequency of use of health insurance drugs by the doctors who use health insurance with general characteristics shows similar differences in case of total monthly sales amount (p<0.001), average number of daily patients (p<0.05). Secondly, as to the willingness of the expanded usage of insurance drugs, similar differences are observed in case of total monthly sales amount (p<0.05). 6. Upon investigating the general characteristics of the perception of Herbal health care drugs, the followings are observed. First, inspecting general characteristics and insurance claims due to increased co-payments(deductible amount) reveals similar differences in case of working period (p<0.01) and in case of total monthly sales amount (p <0.01). Secondly, inspecting general characteristics and the obstacles that hinder granular type drugs from being accepted as health care insurance drugs shows similar differences in case of working period (p<0.05). 7. Upon investigating the general characteristics of the understanding of Oriental Herbal pharmaceutical companies, the followings are observed. First, opinions on the general characteristics of pharmaceutical companies, when examined with variance analysis, shows similar differences in case of total monthly sales amount (p<0.05). Secondly, when opinions are examined on general characteristics and the problems of herbal pharmaceutical companies, similar differences are found in case of working period (p<0.01) and in case of total monthly sales amount (p<0.001). Lastly, opinions on the general characteristics and reforms of pharmaceutical companies, similar differences are observed in case of working period (p<0.001). 8. Upon investigating the general characteristics of the improvement of insurance Herbal drugs, the followings are observed. First, regarding general characteristics and insurance benefits, similar differences are observed in case of working period (p<0.05), in case of total monthly sales amount (p<0.05), and in case of average number of daily patients (p<0.01). Secondly, opinions on the general characteristics and the needs for the improvement of Herbal insurance drugs are examined in 5 different aspects, which are the approval of granular type drugs as insurance drugs, the expanded practices of the number of prescription insurance drugs, the needs of a variety of formulations, the needs of TFT of which numbers of Oriental medical doctors are members for the revision of the existing system, and the needs of adjusting the current ceiling of the fixed amount and the fixed rate. When processed by the analysis of variance, the results show similar differences in case of average number of daily patients (p<0.01). Conclusion : From the results of this study the first measures to take are, to reform overall insurance benefit system, including insurance co-payment system(fixed rate cap adjustment), to expand the number of the herbal drugs to be prescribed matching with insurance benefit accordingly, and to revitalize herbal medicine insurance system through the change of various formulations. In addition, it is recommended to improve the effectiveness of herbal medicine by making plans to enhance the efficacy of herbal medicine and by enabling small pharmaceutical companies to outgrow themselves.

• 한국정보통신학회:학술대회논문집
• /
• 한국해양정보통신학회 2008년도 춘계종합학술대회 A
• /
• pp.249-252
• /
• 2008

유비쿼터스 헬스케어에서의 착용형(Wearable) 생체신호 모니터링 시스템은 가슴 부착형, 손목시계형, 신발, 의복형 등과 같은 형태로 많은 연구들이 진행 중에 있으며, 본 논문에서는 가슴 부착형태의 인체 착용형 다중 생체신호 시스템을 설계하고, 다중 생체신호 모니터링 시스템을 위해 심전도와 3축 가속도 센서를 사용하여 심전도 신호 측정 및 신체 움직임에 따라 변화하는 값을 측정할 수 있도록 구현하였다. 구현한 시스템은 생체센서노드, 센서보드, 생체신호 수집을 위한 베이스스테이션 노드로 구성된다. 생체센서노드는 가슴 부착형으로 신체에 착용하여 사용자의 심전도와 가속도 신호를 계측하도록 설계하였으며, 서버 PC에 연결된 베이스스테이션 노드로 계측된 생체신호를 전송한다. 센서보드는 심전도와 가속도 신호를 측정하기 위한 센서로 구성되며, 생체센서노드와 일체형으로 장착이 가능하도록 설계하였다. 또한, 생체신호 수집을 위한 베이스스테이션 노드는 IEEE 802.15.4 무선통신을 통해 생체센서노드로부터 전송된 생체신호를 수집하여 그 수집된 생체신호를 실시간으로 서버 PC에 디스플레이가 가능하다. 본 논문에서 구현한 시스템을 통해 P, QRS, T파로 구성된 심전도 신호를 계측할 수 있었으며, 계측된 신호에서 심전도 신호의 파형 성분들이 나타남을 확인 할 수 있었다. 또한, 3축 가속도 센서에 의해 신체의 움직임에 따라 변화하는 x, y, z의 3축 가속도 출력 값을 얻을 수 있다.

• The Korean Journal of Pain
• /
• 제31권1호
• /
• pp.27-38
• /
• 2018

Background: Related to escalating health care costs and the questionable effectiveness of multiple interventions including lumbar facet joint interventions, cost effectiveness or cost utility analysis has become the cornerstone of evidence-based medicine influencing coverage decisions. Methods: Cost utility of therapeutic lumbar facet joint nerve blocks in managing chronic low back pain was performed utilizing data from a randomized, double-blind, controlled trial with a 2-year follow-up, with direct payment data from 2016. Based on the data from surgical interventions, utilizing the lowest proportion of direct procedural costs of 60%, total cost utility per quality adjusted life year (QALY) was determined by multiplying the derived direct cost at 1.67. Results: Patients in this trial on average received $5.6{\pm}2.6$ procedures over a period of 2 years, with average relief over a period of 2 years of $82.8{\pm}29.6$ weeks with $19{\pm}18.77$ weeks of improvement per procedure. Procedural cost for one-year improvement in quality of life showed USD $2,654.08. Estimated total costs, including indirect costs and drugs with multiplication of direct costs at 1.67, showed a cost of USD $4,432 per QALY. Conclusions: The analysis of therapeutic lumbar facet joint nerve blocks in the treatment of chronic low back pain shows clinical effectiveness and cost utility at USD $2,654.08 for the direct costs of the procedures, and USD $4,432 for the estimated overall cost per one year of QALY, in chronic persistent low back pain non-responsive to conservative management.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권5호
• /
• pp.3237-3241
• /
• 2013

Background: Under-ascertainment and over-ascertainment are common phenomena in surveillance and registry systems of health-related events. Capture-recapture is one of the methods which is applied to determine the sensitivity of surveillance or registry systems to recognize cancer cases. This study aimed to estimate the number of cancers using data available both in the Cancer Registry Center of Northwestern Iran and in the Population-based Cancer Registry Center of Iran. Material and Methods: The studied population consisted of all cancerous cases in the northwest of Iran from 2008 to 2010. All data were extracted from two resources and entered into Microsoft Excel software. After removing common and repeat cases the data were statistically analyzed using a capture-recapture studies' specific software "CARE 1.4". Estimations were calculated by Chapman and Petersen methods with the approximate confidence interval of 95%. Results: From 2008 to 2010, the number of all cancer cases was estimated to be 21,652 (CI 95%: 19,863-22,101). Sensitivity rate of all cancer cases was 83.9% and that of Population-based Cancer Registry Center of Iran was 52%. It was 93.1% considering both resources. Conclusion: Using two resources and the capture-recapture method rather than a single resource may be a more reliable method to estimate the number of cancer cases.

• Tuberculosis and Respiratory Diseases
• /
• 제85권2호
• /
• pp.165-174
• /
• 2022

Background: One goal of the End tuberculosis (TB) Strategy is to see no TB-affected households experiencing catastrophic costs. Therefore, it is crucial for TB-elimination programs to identify catastrophic costs and their main drivers in order to establish appropriate health and social measures. This study aimed to measure the percent of catastrophic costs experienced by Egyptian TB patients and to identify its determinants. Methods: We conducted a prospective cohort study with 151 Egyptian TB patients recruited from two chest dispensaries from the Cairo governate from May 2019 to May 2020. We used a validated World Health Organization TB patient-cost tool to collect data on patients' demographic information, household income, and direct and indirect expense of seeking TB treatment. We considered catastrophic TB costs to be total costs exceeding 20% of the household's annual income. Results: Of the patients, 33% experienced catastrophic costs. The highest proportion of the total came in the pre-treatment stage. Being the main breadwinner, experiencing job loss, selling property, and the occurrence of early coronavirus disease 2019 lockdown were independent determinants of the incidence of catastrophic costs. Borrowing money and selling property were the most-often reported coping strategies adopted. Conclusion: Despite the availability of free TB care under the Egyptian National TB Program, nearly a third of the TB patients incurred catastrophic costs. Job loss and being the main breadwinner were among the significant predictors of catastrophic costs. Social protection mechanisms, including cash assistance and insurance coverage, are necessary to achieve the goal of the End TB Strategy.

• 대한영상의학회지
• /
• 제81권5호
• /
• pp.1083-1095
• /
• 2020

2019년 비뇨생식기 초음파와 MRI의 보험급여 범위가 확대되어 보다 많은 환자들이 급여로 영상검사를 받을 수 있게 되었다. 비뇨기계 초음파와 MRI는 암 환자 등 중증질환 환자에서 는 기존에도 급여 혜택을 받을 수 있었으나 이번 급여 범위 확대로 초음파의 경우 대부분의 질환, MRI의 경우에도 조직검사 전 전립선암이나 난소암 의증, 자궁근종절제술 시행 전 자궁 MRI, 각종 선천 기형 등 양성질환에서도 급여로 검사가 가능해졌다. 그러나 급여화로 인해 각 검사 별 적응증과 추적검사 가능 질환 및 횟수 등이 복잡해지고 획득하여야 할 표준영상과 언급하여야 하는 판독소견서의 양식이 정해져 있어 검사를 처방하고 시행하는 의사들이 주의해야 할 사항들이 생겼다. 건강보험 적용 기준에 대한 충분한 이해를 통한 진료는 환자들의 진료 결과를 증진시키는 데 도움이 될 것이다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권22호
• /
• pp.10003-10008
• /
• 2014

Background: Cervical cancer has been a leading female cancer in Thailand for decades, and has been second to breast cancer after 2007. The Ministry of Public Health (MoPH) has provided opportunistic screening with Pap smears for more than 30 years. In 2002, the MoPH and the National Health Security Office provided countrywide systematic screening of cervical cancer to all Thai women aged 35-60 years under universal health care coverage insurance scheme at 5-year intervals. Objectives: This study characterized the cervical cancer incidence trends in Songkhla in southern Thailand using joinpoint and age period cohort (APC) analysis to observe the effect of cervical cancer screening activities in the past decades, and to project cervical cancer rates in the province, to 2030. Materials and Methods: Invasive and in situ cervical cancer cases were extracted from the Songkhla Cancer Registry from 1990 through 2010. Age standardized incidence rates were estimated. Trends in incidences were evaluated by joinpoint and APC regression models. The Norpred package was modified for R and was used to project the future trends to 2030 using the power of 5 function and cut trend method. Results: Cervical cancer incidence in Songkhla peaked around 1998-2000 and then dropped by -4.7% per year. APC analysis demonstrated that in situ tumors caused an increase in incidence in early ages, younger cohorts, and in later years of diagnosis. Conclusions: Both joinpoint and APC analysis give the same conclusion in continuation of a declining trend of cervical cancer to 2030 but with different rates and the predicted goal of ASR below 10 or even 5 per 100,000 women by 2030 would be achieved. Thus, maintenance and improvement of the screening program should be continued. Other population based cancer registries in Thailand should analyze their data to confirm the success of cervical cancer screening policy of Thailand.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권6호
• /
• pp.2465-2472
• /
• 2015

Background: The Quality Audit (BQA) program of the Breast Surgeons of Australia and New Zealand (NZ) collects data on early female breast cancer and its treatment. BQA data covered approximately half all early breast cancers diagnosed in NZ during roll-out of the BQA program in 1998-2010. Coverage increased progressively to about 80% by 2008. This is the biggest NZ breast cancer database outside the NZ Cancer Registry and it includes cancer and clinical management data not collected by the Registry. We used these BQA data to compare socio-demographic and cancer characteristics and survivals by ethnicity. Materials and Methods: BQA data for 1998-2010 diagnoses were linked to NZ death records using the National Health Index (NHI) for linking. Live cases were followed up to December $31^{st}$ 2010. Socio-demographic and invasive cancer characteristics and disease-specific survivals were compared by ethnicity. Results: Five-year survivals were 87% for Maori, 84% for Pacific, 91% for other NZ cases and 90% overall. This compared with the 86% survival reported for all female breast cases covered by the NZ Cancer Registry which also included more advanced stages. Patterns of survival by clinical risk factors accorded with patterns expected from the scientific literature. Compared with Other cases, Maori and Pacific women were younger, came from more deprived areas, and had larger cancers with more ductal and fewer lobular histology types. Their cancers were also less likely to have a triple negative phenotype. More of the Pacific women had vascular invasion. Maori women were more likely to reside in areas more remote from regional cancer centres, whereas Pacific women generally lived closer to these centres than Other NZ cases. Conclusions: NZ BQA data indicate previously unreported differences in breast cancer biology by ethnicity. Maori and Pacific women had reduced breast cancer survival compared with Other NZ women, after adjusting for socio-demographic and cancer characteristics. The potential contributions to survival differences of variations in service access, timeliness and quality of care, need to be examined, along with effects of comorbidity and biological factors.